This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

Nordhealth As
8/18/2026
Hello everyone, and welcome to Nord Health's Capital Markets Day 2026.
My name is Alex Cram. I'm the CFO at Nord Health.
And I want to start by just saying a big thank you to all of our in-person attendees for traveling to London to come and see us today. We have investors from all of the Nordic countries, the UK, Germany, France. And so I want to say a big, big thank you to everyone who's traveled, especially our guest speakers who've come from the UK. But we really appreciate that they'll do a fireside panel for us later. We have a fantastic agenda for you today. We're going to start off by going into our group vision and long-term objectives. We're going to have a deep dive on the veterinary business and strategy. We're going to follow that up by a look at our AI products and our vision for AI. We'll take a short break at that point, and then after that, we'll have the fireside channel with two of the largest veterinary groups in the UK. After that, we're going to go into our therapy business, and then we'll finish up with financials and guidance. Today's presenters are Charles McBain, our group CEO, James Stanier, the CTO of our veterinary business, Karan Walia, the CEO of our therapy business, and then me. And with that, I will turn over to Charles for our group vision.
You're reading a preview of the NRDHF Q2 2026 earnings call.
Free account.